704 related articles for article (PubMed ID: 7563509)
1. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
2. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
Zurn P; Danthine JP
Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
[TBL] [Abstract][Full Text] [Related]
3. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
[TBL] [Abstract][Full Text] [Related]
5. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
Krahn M; Detsky AS
Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
[TBL] [Abstract][Full Text] [Related]
7. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.
Mast EE; Margolis HS; Fiore AE; Brink EW; Goldstein ST; Wang SA; Moyer LA; Bell BP; Alter MJ;
MMWR Recomm Rep; 2005 Dec; 54(RR-16):1-31. PubMed ID: 16371945
[TBL] [Abstract][Full Text] [Related]
9. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
Harris A; Yong K; Kermode M
Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
11. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
[TBL] [Abstract][Full Text] [Related]
12. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccination--United States, 1982-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(25):549-52, 563. PubMed ID: 12118536
[TBL] [Abstract][Full Text] [Related]
14. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
15. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
[TBL] [Abstract][Full Text] [Related]
16. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
[TBL] [Abstract][Full Text] [Related]
17. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
18. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis.
Fendrick AM; Lee JH; LaBarge C; Glick HA
Arch Pediatr Adolesc Med; 1999 Feb; 153(2):126-36. PubMed ID: 9988242
[TBL] [Abstract][Full Text] [Related]
20. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
Sun PP; Zhang SX; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
